Cargando…
Dual Recombinase–Based Mouse Models Help Decipher Cancer Biology and Targets for Therapy
The advent of next-generation sequencing (NGS) and single-cell profiling technologies has revealed the complex and heterogenous ecosystem of human tumors under steady-state and therapeutic perturbation. Breakthroughs in the development of genetically engineered mouse models (GEMM) of human cancers t...
Autores principales: | Sket, Tina, Falcomatà, Chiara, Saur, Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351565/ https://www.ncbi.nlm.nih.gov/pubmed/37449355 http://dx.doi.org/10.1158/0008-5472.CAN-22-2119 |
Ejemplares similares
-
Targeting the P53 Protein for Cancer Therapies: The Translational Impact of P53 Research
por: Levine, Arnold J.
Publicado: (2022) -
Targeting Mutated p53: Naivete and Enthusiasm to Attempt the Impossible
por: El-Deiry, Wafik S.
Publicado: (2023) -
Addressing Common Misuses and Pitfalls of P values in Biomedical Research
por: Wang, Ming, et al.
Publicado: (2022) -
Translating “Big Data” in Oncology for Clinical Benefit: Progress or Paralysis
por: Barker, Anna D., et al.
Publicado: (2022) -
Cancer Needs a Robust “Metadata Supply Chain” to Realize the Promise of Artificial Intelligence
por: Chung, Caroline, et al.
Publicado: (2021)